Administration of 16.alpha.,17.alpha.-cyclopentylidenedioxy-9.al

Details Administration of 16.alpha.,17.alpha.-cyclopentylidenedioxy-9.al Administration of 16.alpha.,17.alpha.-cyclopentylidenedioxy-9.al

1976-12-28

1979-06-12

Love, Ethel G.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

26023955D, A61K 3158

Patent

active

041580559

ABSTRACT:
A method of treating topical inflammation in mammals by the administration of 16.alpha.,17.alpha.-cyclopentylidenedioxy-9.alpha.-fluoro-11.beta.,21-dihy droxy-1,4-pregnadiene-3,20-dione 21-acetate in a pharmaceutically acceptable carrier.

REFERENCES:
patent: 3048581 (1962-08-01), Fried
patent: 3053836 (1962-09-01), Fried
patent: 3541602 (1970-11-01), Diassi
patent: 3856954 (1974-12-01), Jackson
patent: 3867528 (1975-02-01), Ritter et al.
Applezweig, Steroid Drugs, p. 307, McGraw-Hill Book Co., Inc. 1962.
McKenzie, "Percutaneous Absorption of Steroids", vol. 86 (1962), Archives of Dermatology, pp. 611-614.
McKenzie, "Topical Activites of Betamethusone Esters in Man", Archives of Dermatology, vol. 89, (1964), pp. 741-746.

Affiliated with

Also associated with

Rating

Administration of 16.alpha.,17.alpha.-cyclopentylidenedioxy-9.al does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Administration of 16.alpha.,17.alpha.-cyclopentylidenedioxy-9.al, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Administration of 16.alpha.,17.alpha.-cyclopentylidenedioxy-9.al will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1109764